BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19487938)

  • 1. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.
    Spreer A; Lugert R; Stoltefaut V; Hoecht A; Eiffert H; Nau R
    Crit Care Med; 2009 Jul; 37(7):2253-8. PubMed ID: 19487938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis.
    Böttcher T; Gerber J; Wellmer A; Smirnov AV; Fakhrjanali F; Mix E; Pilz J; Zettl UK; Nau R
    J Infect Dis; 2000 Jun; 181(6):2095-8. PubMed ID: 10837202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
    Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M
    Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone.
    Böttcher T; Ren H; Goiny M; Gerber J; Lykkesfeldt J; Kuhnt U; Lotz M; Bunkowski S; Werner C; Schau I; Spreer A; Christen S; Nau R
    J Neurochem; 2004 Dec; 91(6):1450-60. PubMed ID: 15584921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment.
    Kanegaye JT; Soliemanzadeh P; Bradley JS
    Pediatrics; 2001 Nov; 108(5):1169-74. PubMed ID: 11694698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
    Destache CJ; Pakiz CB; Dash AK; Larsen C
    Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis.
    Nau R; Wellmer A; Soto A; Koch K; Schneider O; Schmidt H; Gerber J; Michel U; Brück W
    J Infect Dis; 1999 Jun; 179(6):1557-60. PubMed ID: 10228082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone.
    Gerber J; Pohl K; Sander V; Bunkowski S; Nau R
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1313-7. PubMed ID: 12654664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin is neuroprotective in experimental Streptococcus pneumoniae meningitis.
    Gerber J; Lotz M; Ebert S; Kiel S; Huether G; Kuhnt U; Nau R
    J Infect Dis; 2005 Mar; 191(5):783-90. PubMed ID: 15688296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing the release of proinflammatory and toxic bacterial products within the host: a promising approach to improve outcome in life-threatening infections.
    Nau R; Eiffert H
    FEMS Immunol Med Microbiol; 2005 Apr; 44(1):1-16. PubMed ID: 15780573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis.
    Buckingham SC; McCullers JA; Luján-Zilbermann J; Knapp KM; Orman KL; English BK
    Pediatrics; 2006 May; 117(5):1688-94. PubMed ID: 16651325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
    Trostdorf F; Reinert RR; Schmidt H; Nichterlein T; Stuertz K; Schmitz-Salue M; Sadowski I; Brück W; Nau R
    J Antimicrob Chemother; 1999 Jan; 43(1):87-94. PubMed ID: 10381105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis.
    Lutsar I; Friedland IR; Jafri HS; Wubbel L; Ahmed A; Trujillo M; McCoig CC; McCracken GH
    J Antimicrob Chemother; 2003 Oct; 52(4):651-5. PubMed ID: 12951330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
    Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.
    Klein M; Koedel U; Pfister HW; Kastenbauer S
    Ann Neurol; 2003 Oct; 54(4):451-8. PubMed ID: 14520656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis.
    Lee H; Song JH; Kim SW; Oh WS; Jung SI; Kiem S; Peck KR; Lee NY
    Int J Antimicrob Agents; 2004 Mar; 23(3):307-10. PubMed ID: 15164975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of post-meningitic cochlear injury with cerebrospinal fluid irrigation.
    Yeung AH; Tinling SP; Brodie HA
    Otolaryngol Head Neck Surg; 2006 Feb; 134(2):214-24. PubMed ID: 16455367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.